tetano
Editor, Senior Moderator
Paediatr Child Health. 2018 Dec;23(8):563-564. doi: 10.1093/pch/pxy148. Epub 2018 Nov 19.
[h=1]The use of antiviral drugs for influenza: Guidance for practitioners.[/h] [Article in English, French]
Allen UD[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This practice point summarizes the use of antiviral drugs to manage influenza illness in children and youth. Recommendations are based on previously published Canadian recommendations for clinicians on the use of antiviral drugs to prevent and treat influenza. Detailed information on the selective use of chemoprophylaxis can be found in the original document, which also highlights the importance of secondary bacterial infections (i.e., Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus and methicillin-resistant S aureus) in cases of severe influenza illness. This document serves as a reference for all clinicians while providing general principles and a user-friendly flow diagram to assist decision-making.
[h=4]KEYWORDS:[/h] Antiviral therapy; Children; Influenza; Neuraminidase inhibitors
PMID: 31043845 PMCID: PMC6242040 [Available on 2019-12-01] DOI: 10.1093/pch/pxy148
[h=1]The use of antiviral drugs for influenza: Guidance for practitioners.[/h] [Article in English, French]
Allen UD[SUP]1[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] This practice point summarizes the use of antiviral drugs to manage influenza illness in children and youth. Recommendations are based on previously published Canadian recommendations for clinicians on the use of antiviral drugs to prevent and treat influenza. Detailed information on the selective use of chemoprophylaxis can be found in the original document, which also highlights the importance of secondary bacterial infections (i.e., Streptococcus pneumoniae, methicillin-sensitive Staphylococcus aureus and methicillin-resistant S aureus) in cases of severe influenza illness. This document serves as a reference for all clinicians while providing general principles and a user-friendly flow diagram to assist decision-making.
[h=4]KEYWORDS:[/h] Antiviral therapy; Children; Influenza; Neuraminidase inhibitors
PMID: 31043845 PMCID: PMC6242040 [Available on 2019-12-01] DOI: 10.1093/pch/pxy148